BGBoris Dmitrievich Giller

Boris Dmitrievich Giller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Boris Dmitrievich Giller has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The outcome determinants in tuberculous empyema: a 20-year multicenter cohort study

    by Boris Giller, Galina Shcherbakova, Oleg Kesaev, Murat Shogenov, Sergey Smerdin, Michael Peer, Dmitry Giller

    Objectives: Tuberculous empyema (TE) remains a complex clinical entity with poorly defined determinants of outcomes. This study aimed to evaluate the relative impact of treatment strategy, microbiological characteristics, and disease stage on relapse, residual radiological changes, and duration of pleural exudation in a large multicenter cohort. Methods: A retrospective multicenter study was conducted including patients treated between 2003 and 2023 across three specialized tuberculosis centers. Multivariable logistic regression was used to identify predictors of relapse and residual radiological alterations. Duration of pleural exudation was analyzed using a generalized linear model with gamma distribution and log link function. Collinearity between stage and treatment was addressed by constructing separate models. Results: Of 1052 screened patients 420 met inclusion criteria. Localized empyema was associated with reduced residual disease (OR 0.30, p < 0.001) and relapse (OR 0.50, p = 0.001). Open surgery was associated with lower odds of residual radiological alterations (OR 0.14, p = 0.002) and relapse (OR 0.07, p < 0.001), as well as a shorter expected duration of pleural exudation (exp(B) 0.162). VATS was associated with lower odds of relapse (OR 0.09, p < 0.001) and a shorter expected duration of pleural exudation (exp(B) 0.186) but was not associated with residual radiological alterations. Conclusions: Outcomes in TE were primarily associated with microbiological burden and treatment strategy. Surgical intervention, particularly open procedures, was associated with faster disease resolution and lower relapse rates, whereas AFB positivity and drug resistance were associated with persistent and prolonged disease. Early identification of high-risk patients and timely surgical management may be important for optimizing outcomes. Clinical registration number: The present retrospective observational study was retrospectively registered with ISRCTN (ISRCTN11977620) on April 10, 2026.

  • Treatment outcomes in patients with tuberculous pleural empyema

    by G.V. Shcherbakova, D.B. Giller, B.D. Giller, O.SH. Kesaev, V.V. Koroev, I.I. Enilenis, I.I. Martel, M.S. Shogenov, A.A. Filatov

    Objective. To improve treatment of patients with pleural tuberculosis. Material and methods. We analyzed medical records of 887 patients. All patients received treatment for pleural tuberculosis and pulmonary tuberculosis complicated by pleural tuberculosis between 2003 and 2022. Patients were divided into three groups. Group I included 211 patients with stage I pleural tuberculosis; group II — 73 patients with stage II pleural tuberculosis; group III — 603 patients with stage III pleural tuberculosis. Results. Comprehensive treatment incorporating surgical methods was performed in 743 patients. Among 1.338 surgical procedures, intraoperative complications occurred in 48 (3.6%) cases. These were injury of major vessels in 10 cases, opening of empyema in 29 cases, injury of pleural sac during transsternal occlusion of the main bronchus in 10 cases and diaphragmatic injury in 1 case. Postoperative complications were observed in 90 patients (6.7%). Ten (1.13%) patients died in a hospital, and all ones underwent surgery for stage III empyema. As a result of comprehensive treatment with surgical methods, tuberculous empyema regressed at discharge in 721 (97%) patients. Empyema was cured in all patients with stage I and II, as well as in 581 patients (96.4%) with stage III disease. Conclusion. Immediate outcomes of comprehensive surgical treatment of pleural and pulmonary tuberculosis complicated by tuberculous empyema largely depend on stage of pleural empyema. Stage I patients achieved full treatment response without complications or mortality. Stage II patients (95.9%) did not achieve full treatment response with closure of lung cavities and cessation of bacterial excretion, despite elimination of empyema and no mortality. Treatment of stage III tuberculous empyema was associated with the highest incidence of intraoperative (3.9%) and postoperative (7.3%) complications, in-hospital mortality (1.66%) and lower efficacy (90.9%).

  • Open Access

    Thoracoscopic lobectomy for early-stage non-small cell lung carcinoma: initial experience from a newly established Israeli center

    by Boris Giller, Sharbel Azzam, Nahum Nesher, Marina Kolody, Yacov Abramov, Vladimir Varenkin, Ruth Shaylor, Idit Matot, Ofer Merimsky, Michael Peer

    Video-assisted thoracoscopic surgery (VATS) lobectomy has emerged as the standard surgical procedure for early-stage non-small cell lung cancer (NSCLC). This article presents the initial experience of a newly established thoracic surgery department with a residency program, evaluating surgical, oncologic and safety outcomes while implementing a learning environment. This single-center retrospective study analyzed medical records of patients who underwent VATS lobectomy for early-stage NSCLC between 2019 and 2024. Inclusion criteria were age over 18 years, NSCLC pathology, and clinical stage IA–IIB. The patient population was divided into two subgroups, the first consisting of procedures performed exclusively by senior surgeons and the second consisting of those performed by residents under direct supervision. Key outcomes were mortality, overall complication, and overall survival rates. A total of 460 patients were evaluated, with a mean age of 69.7 years; the cohort was predominantly male. Adenocarcinoma was the most common pathology (81.1%), with right upper lobe resection being the most frequent procedure. The conversion rate to thoracotomy was 4.1%, with senior surgeons reporting a rate of 8.7% compared to 0.7% among residents. Thirty-day mortality was 1.73%, with senior surgeons at 1.02% and residents at 2.26%. Overall complication rate reached 26.7% without a difference in the subgroups. Prolonged hospitalization occurred in 26.9% of cases. Five-year overall survival was 90.42% among the 94 patients with adequate follow-up, demonstrating favorable outcomes for minimally invasive surgery in early-stage lung cancer. This single-center experience demonstrates that VATS lobectomy is a safe and effective treatment for early-stage NSCLC, yielding outcomes comparable to those reported globally. The study findings reaffirm VATS as a current standard of care, providing robust postoperative survival and manageable complication rates. Furthermore, study indicates that VATS lobectomy is also a safe procedure for training surgical residents, supporting its role in surgical education.

  • Risk factors for bronchopleural complications after pneumonectomy

    by D.B. Giller, B.D. Giller, S.V. Smerdin, A.E. Ergeshov, S.S. Saenko, G.V. Shcherbakova, M.A. Kulaeva, I.I. Martel

    Objective. To assess various risk factors for bronchopleural complications, as well as effectiveness of some techniques for bronchial stump closure and covering. Material and methods. We studied the results of 2022 pneumonectomies between 1958 and 2023. Different techniques for bronchial stump closure and covering were used. We studied the influence of the following factors on the incidence of bronchial fistula: pulmonary disease; pulmonary lesion complicated by bleeding, empyema; acute progression of tuberculosis as caseous pneumonia; Mycobacterium tuberculosis with multiple and extensive drug resistance; tuberculosis of the main bronchus; preoperative destructive tuberculosis-related lesion of contralateral lung; pulmonary gangrene; partial resection of cancer; extended bilateral lymph node dissection, etc. Results. The incidence of bronchopleural complications and mortality significantly decreased over time. Nevertheless, these events remained the main cause of death after pneumonectomy until the last decade. Most often, death following bronchopleural complications was noted in patients with bronchial fistula within 21 days. Among 111 patients with this complication, 48 (43.24%) ones died. Conclusion. According to our data, bronchial suturing technique and side of surgery are the most significant factors regarding the incidence of bronchial fistula. The highest risk is associated with surgery for pulmonary gangrene, the lowest risk — with total resection of cancer. The incidence of delayed bronchial fistula in tuberculosis exceeds the incidence of early bronchial fistula.

  • Open Access

    Surgical treatment of bilateral vanishing lung syndrome: a case report

    by Dmitry Borisovich Giller, Galina Vladimirovna Scherbakova, Boris Dmitrievich Giller, Arkadyi Leybovich Khanin, Vladimir Nikolayeich Nikolenko, Mikhail Yegorovich Sinelnikov

    Background: Volume reduction surgery is a routine treatment method for lung emphysema in chronic obstructive pulmonary disease (COPD) patients. The formation of giant bullous emphysema is an indication for surgical bullectomy. Bilateral giant bullae severely compromise lung function and complicate surgical treatment. Case presentation: We present the algorithm for surgical treatment and correction of complications in a 38-year-old male with bilateral giant bullae (vanishing lung syndrome), severe COPD. Primarily the patient was admitted with a mild cough, mucopurulent sputum and dyspnea. A CT scan revealed bilateral giant bullae, displacing up to 50% of lung volume. A two-stage surgical bullectomy was planned, yet postoperative complications due to secondary bullae rupture prompted urgent revision with contralateral bullae resection. After complete bullectomy, severely reduced lung volume was successfully managed throughout a long postoperative rehabilitation period. At 5 year follow-up, spirometry indicators and radiological examination show significantly improved and stable lung function. Conclusion: This clinical case demonstrates the technical difficulties and possible complications of extended bilateral lung resections in patients with severe vanishing lung syndrome. Single-stage treatment of bilateral giant bullous emphysema is recommended to minimize postoperative complications and reduce risk of bullae rupture. Positive long-term outcome outweighs possible complications of surgical treatment.


  • Open Access

    Extensive tracheal resection in lung cancer and tuberculosis: a case report

    by Dmitry Giller, Boris Giller, Galina Scherbakova, Elizaveta V. Mikhaylenko, Liudmila M. Mikhaleva, Vladimir N. Nikolenko, Liliya V. Gavryushova, Siva G. Somasundaram, Cecil E. Kirkland, Gjumrakch Aliev

    Background: Tracheal bifurcation resection remains the greatest challenge in airway reconstruction, especially with extensive lesions. Additionally, lung cancer and pulmonary tuberculosis comorbidity complicate the chemoradiotherapy treatment due to the TB reactivation. This case describes tracheal resection in a patient with both tuberculosis (TB) and lung cancer. Case presentation: The patient was diagnosed with right lung tuberculosis and upper lobe cancer with trachea invasion complicated by hemoptysis. A right pneumonectomy with circular trachea bifurcation resection was performed. Radiotherapy and chemotherapy were not administered to avoid TB reactivation. At 5.5 years post-surgery, there was cancer recurrence that was treated with radiation therapy. At 10 years post-surgery, an invasive squamous-cell carcinoma of a three-segment bronchus on the left was revealed. Radiation therapy and a course of chemotherapy were carried out with almost complete tumor regression. Conclusions: TB presence should not serve as a basis for the refusal of cancer treatment. Combined treatment may be recommended when the main infection focus in the pulmonary parenchyma is removed during surgery.


  • Open Access

    Video-assisted thoracoplasty in pulmonary tuberculosis: a retrospective study

    by Dmitry B. Giller, Boris D. Giller, Galina V. Giller, Galina V. Scherbakova, Vadim V. Koroev, Oleg Sh. Kesaev, Yakub G. Imagozhev, Aleksey A. Glotov

    Background: The long history of the struggle against tuberculosis (TB) inspired us to develop a new minimally invasive technique of thoracoplasty with videothoracoscope control (VATP). The aim of this study was to determine its efficacy. Methods: We conducted a retrospective single-center study of a cohort of patients operated on between 1999 and 2017. Two hundred eight patients who were indicated for thoracoplasty with verified TB with cavities in the upper lobe/S6 were enrolled in this study. Treatment outcomes were assessed based on Laserson criteria and active TB absence verified with CT. Results: Intraoperative and postoperative complications were observed in 15 (7.2%) and 4 (2.0%) cases, respectively. There were no 30-day mortalities. VATP with curative intent succeeded in 88% of cases according to Laserson criteria and active TB absence verified with computed tomography (CT). Clinical improvement (sputum negativity, closure of caverna, and lack of reactivation for 3 years) was achieved in 81% of cases. Conclusions: Comparing the successful results of this technique in the cohort of multidrug-resistant (MDR) TB patients with the outcomes of treatment of MDR TB worldwide (77% vs. 55%, respectively), the VATP technique is shown to be efficacious and thus recommended. Clinical trial registry number: ISRCTN67743278.


  • Open Access

    Single lung resection

    by Dmitry B. Giller, Jens C. Rückert, Boris B. Giller, Oleg Sh. Kesaev, Yakub G. Imagozhev, Galina V. Scherbakova

    Introduction: Single lung resection remains a challenge due to the preservation of the respiratory reserve. This report presents that case of a female patient with bilateral fibrotic-cavitary pulmonary tuberculosis complicated with empyema on the right lung. Only 3.5 lung segments were left after a multistage surgery. Presentation of case: The first stage included draining of empyema and transsternal transmediastinal right main bronchus occlusion. Then, upper lobectomy with partial S6 resection of the left lung, followed by pleuropneumonectomy was performed. At a follow-up of two years and 10 months, patient’s condition was good. Discussion: Although single lung surgery has been possible over half a century ago, it remains a high-risk intervention. Conclusion: With the removal of the non-functioning parenchyma and elimination of the air/vascular shunt, single lung resection volume exceeding lobectomy is possible, which may improve cardiorespiratory function. Highlights:


  • Open Access

    Surgical treatment of giant bullae on the background of cystic lesion and vascular malformation. Case report

    by B. Giller Dmitry, D. Giller Boris, P. Severova Lyudmila, S. Berezovsky Yuri, I. Martel Ivan


  • Radiodiagnosis of Pneumonodular Fistula as a Rare Complication of Tuberculous Mediastinitis in a Teenager with Generalized Tuberculosis

    by D. B. Giller, Ya. V. Lazareva, I. I. Martel’, A. I. Shekhter, O. N. Ots, O. P. Frolova, G. V. Shcherbakova, B. D. Giller

    The low incidence of nodular fistulas can create difficulties in diagnosis and timely treatment. This clinical observation describes the diagnosis of pneumonodular fistula in a female patient with tuberculosis at multiple sites as a complication of tuberculous mediastinitis. It describes the surgical treatment received by this patient and its outcome as an example of correct treatment policy for this complication.